These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3882761)

  • 21. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
    Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
    Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation.
    Ozbek U; Vural B; Kalayoğlu S; Soysal T; Bilgen H; Yavuz S; Anak S; Sargin D; Gedikoğlu G; Ferhanoğlu B; Akoğlu T; Tangün Y; Ozçelik T
    Turk J Pediatr; 1997; 39(3):303-11. PubMed ID: 9339108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chimerism monitoring by VNTRs polymorphism analysis in a patient who received allogenic bone marrow transplantation].
    Banno S; Nitta M; Wakita A; Iwaki O; Takeuchi G; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1992 Aug; 33(8):1098-100. PubMed ID: 1404867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease.
    Gyger M; Baron C; Forest L; Lussier P; Lagacé F; Bissonnette I; Bélanger R; Bonny Y; Busque L; Roy DC; Perreault C
    Exp Hematol; 1998 May; 26(5):426-34. PubMed ID: 9590660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA typing for bone marrow engraftment follow-up after allogeneic transplant: a comparative study of current technologies.
    Leclair B; Frégeau CJ; Aye MT; Fourney RM
    Bone Marrow Transplant; 1995 Jul; 16(1):43-55. PubMed ID: 7581128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation monitoring by DNA analysis.
    Gasparini P; Martinelli G; Trabetti E; Ambrosetti A; Benedetti F; Pignatti PF
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():157-9. PubMed ID: 2627619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One haplotype matched bone marrow grafts: an investigation using the HLA system as a marker of cellular origin.
    Jones EH; Lawler SD; Powles RL
    Dis Markers; 1988 Mar; 6(1):47-55. PubMed ID: 3293882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor engraftment after allogeneic bone marrow transplantation: role of chimerism analysis in treatment and outcome.
    Au WY; Chan EC; Lie AK; Liang R; Leung AY; Ma SK; Kwong YL
    Ann Hematol; 2003 Jul; 82(7):410-5. PubMed ID: 12750845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
    Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
    Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of short tandem repeats with fluorescence labeling polymerase chain reaction to document engraftment following allogeneic bone marrow transplantation].
    Xiao L; Guo K; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):418-22. PubMed ID: 11718093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of DNA polymorphisms to monitor engraftment after allogeneic bone marrow transplantation.
    Rothberg PG; Gamis AS; Baker D
    Clin Lab Med; 1997 Mar; 17(1):109-18. PubMed ID: 9138894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors.
    Yabe H; Yabe M; Hattori K; Hinohara T; Morimoto T; Nakamura Y; Noma M; Takei M; Kobayashi N; Tsuji K; Kato S
    Bone Marrow Transplant; 1996 Jun; 17(6):985-91. PubMed ID: 8807104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed engraftment and mixed chimerism after HLA-identical sibling donor BMT in Fanconi anaemia.
    Mital MK; Curtis A; Spencer V; Barge D; Skinner R
    Bone Marrow Transplant; 1999 Jul; 24(2):201-4. PubMed ID: 10455350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.